About: Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 09 August 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2007 (uk) article scientifique publié en 2007 (fr) im August 2007 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 09 August 2007 (en) artículu científicu espublizáu n'agostu de 2007 (ast) 2007 ആഗസ്റ്റ് 9 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം (ml)
publication date	wds:Q62392233-D08FADAA-BB48-4A19-85C8-ED85321301BC
publication date	2007-08-09 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q62392233-90C62E4D-8955-48C0-A4D7-B6982B05CD0E
language of work or name	English
exact match	wds:Q62392233-475C6990-0AD4-4BDF-9158-1B577D9548C6
exact match	https://scigraph.springernature.com/pub.10.1007/s10549-007-9688-3
author name string	wds:Q62392233-2CAFDB8F-19C0-4976-AE1C-A5E3876BF125 wds:Q62392233-3D7BBDFE-D626-4173-9832-46B5E6327ED8 wds:Q62392233-8B0CAE44-BE18-4550-9C3E-2BEF9DE73BFA wds:Q62392233-8C219721-8CA6-4BEE-A7A8-D72CD33708A6 wds:Q62392233-9AA8E236-984A-4EF8-AFC7-FE5ED0FE1B7A wds:Q62392233-A45C45A4-ED8F-4BD7-8ABB-9964E95185B3 wds:Q62392233-B1C53613-13EA-4B8D-BAB9-B000BAA4879B wds:Q62392233-B67A2414-21E4-4D87-BFB4-1C8AFC9C1B94 wds:Q62392233-B7B69CC2-7F37-4E73-A950-72DB2B244C6A wds:Q62392233-BDAC9330-5991-4E9A-BAFB-A3648C93AC87 wds:Q62392233-D8D4509E-0157-4C88-B222-82F7FED8DED0 wds:Q62392233-EC7E68FA-145C-4A7B-A211-2645859DE84D
author name string	Corrado Boni Gordana Jovic Alberto Bottini Giuseppe Banna Guido Ficarra Simona Giovannelli Beatrice Di Blasio Nicola Battelli Giancarlo Bisagni Andrea Michelotti Claudia Andreetta Nicola Cresti
rdfs:label	Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer (en) Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer (nl)
skos:prefLabel	Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer (en) Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer (nl)
name	Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer (en) Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer (nl)
author	wds:Q62392233-2175B56B-E2BA-4674-876B-56BFE3BBEE49 wds:Q62392233-2C0F1F70-D869-43D3-8B8B-E7459F1994C0 wds:Q62392233-3AB9DC89-588B-4114-AF61-371973DF33D8 wds:Q62392233-95C006C4-E4ED-4431-B8F5-3467609A0489 wds:Q62392233-AB700556-734E-4578-A68F-FF05E95DB0AB wds:Q62392233-B12D1A36-9DF4-403A-B8D6-C255046AE584 wds:Q62392233-B3B7C6DE-59F0-4F5D-A426-6D4E97B66C2A wds:Q62392233-C1ADA401-87AD-4631-9516-D245214050A1
author	Armando Santoro Pierfranco Conte Rossana Berardi Fabio Puglisi Valentina Guarneri Antonino Maiorana Federico Piacentini Antonio Frassoldati
title	wds:Q62392233-673B4381-1526-42CF-96E8-C0DCE5730139
title	Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer (en)
page(s)	wds:Q62392233-7423D370-0E36-41CD-8B9B-2961B0743F79
page(s)	127-134
instance of	wds:Q62392233-3E0608A5-B62A-404E-B785-A4190AEDB3D0
instance of	scholarly article
main subject	wds:Q62392233-705FC185-724A-45B0-8B5D-AAE53C78C155 wds:Q62392233-E94F99B9-5257-459C-95AD-A3C1B7CDD9CC
main subject	biomarker phase II clinical trial
PubMed ID	wds:Q62392233-55722161-810B-40EC-AEBC-031F3F81AD57
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17687648
PubMed ID	17687648
published in	wds:Q62392233-C54322FB-1F28-4A8E-A715-A89B3A0AD04E
published in	Breast Cancer Research and Treatment
issue	wds:Q62392233-EED1ABFE-A5D0-426B-B6FA-7F1CA0EB726A
volume	wds:Q62392233-95F4EB6B-ADCB-43B3-9740-B54FBFB3FF6A
issue	1
volume	110
DOI	wds:Q62392233-5FAB3F70-69BF-4022-929C-FB8D84936E9C
DOI	http://dx.doi.org/10.1007/S10549-007-9688-3
DOI	10.1007/S10549-007-9688-3
Dimensions Publication ID	wds:Q62392233-38294D82-1F8C-4988-B252-2431C69205B1
Dimensions Publication ID	1035300897
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q62392233
is cites work of	Biomarkers of cell death applicable to early clinical trials Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence Relapsed triple-negative breast cancer: challenges and treatment strategies The risk for anemia with targeted therapies for solid tumors Role for the epidermal growth factor receptor in chemotherapy-induced alopecia
is cites work of	wds:Q38000847-3A97F874-4E45-41E4-ADE7-DBA9398CCF63 wds:Q38120666-FFEA42DF-81CA-402D-AE6E-A99A5B4E1EAF wds:Q35989994-DF062F6B-38FC-40BF-8237-CA6D4AE94273 wds:Q36250585-780ADAAC-A83A-4640-884A-7922E86FF056 wds:Q37027934-C7B03A29-73EE-40C0-B941-C9A5F06735F0

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software